Ribociclib-Letrozole Regimen Tested in Ovarian, Endometrial Cancer
July 23, 2019 5:00 pmBy Dave Levitan
A phase II study found that the combination of ribociclib and letrozole showed promising activity in patients with estrogen receptor-positive ovarian cancer and endometrial cancer. The most benefit was observed in low-grade serous ovarian cancers.
“Up to … Read more